Vientiane: The meeting was co-chaired by Mr. Souksavat Sihapanya, Director General of the Department of Science Management under Laos' Ministry of Education and Sports and ASEAN Senior Official on Science, Technology and Innovation (COSTI), and Mr. Okada Shinsuke, Director of the International Cooperation Division at Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT). Senior ASEAN COSTI officials and Japanese representatives also participated. According to Lao News Agency, Mr. Souksavat described Japan as one of ASEAN's most trusted and longstanding partners in science and technology, highlighting the achievements of bilateral cooperation in research, human resource development, technology transfer, and innovation. He thanked Japan for its continued support in advancing ASEAN's science and technology agenda and expressed confidence that the discussions would help identify new opportunities and strengthen future collaboration for the benefit of the region. Participants reaffirmed the importance of ASEAN-Japan cooperation in supporting the ASEAN Plan of Action on Science, Technology and Innovation (APASTI) 2026-2035 and advancing the shared goal of building a strong, sustainable, and competitive ASEAN through innovation and scientific development. The meeting concluded with a renewed commitment to expanding practical cooperation and fostering partnerships that promote research, technological advancement, and sustainable economic growth across the region.
Related Articles
LTO suspends 3 more driving schools for fraudulent certificates
Manila: The Land Transportation Office (LTO) on Monday suspended three more driving schools in Metro Manila and Cavite for alleged fraudulent issuance of theoretical (TDC) and practical driving course (PDC) certificates.
In a statement, LTO chief Ass…
Lao Red Cross Reviews 2024 Voluntary Blood Donation Efforts, Sets Higher Target for 2025
Vientiane: The National Blood Transfusion Center of the Lao Red Cross, in collaboration with private secondary schools, convened its annual meeting to assess the results of the 2024 voluntary blood donation campaign and set out the action plan for 202…
Samsung Biologics 2024 Net Profit Surges 26 Percent on Record Sales
Seoul: Samsung Biologics Co., a biotech arm of the Republic of Korea’s Samsung Group, has reported a significant 26.3 percent increase in its 2024 net profit, amounting to 1.08 trillion won (US$753 million). This growth is attributed to record sales a…
